Allied Biotech Corporation
Allied Biotech Corporation manufactures and sells carotenoids worldwide. Its products include Beta-Carotene that offers yellow to reddish orange shades to appeal color in various applications; Beta-Apo-8'-Carotenal, which is used as a food colorant, and provides a range of orange to red shades; and Lycopene, which offers a range of red shades as a nutrient for food, dietary supplements, and pharm… Read more
Allied Biotech Corporation (1780) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.050x
Based on the latest financial reports, Allied Biotech Corporation (1780) has a cash flow conversion efficiency ratio of 0.050x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$59.06 Million) by net assets (NT$1.19 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Allied Biotech Corporation - Cash Flow Conversion Efficiency Trend (2020–2024)
This chart illustrates how Allied Biotech Corporation's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Allied Biotech Corporation Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Allied Biotech Corporation ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Micro Silicon Electronics Co., Ltd.
TW:8162
|
0.068x |
|
Groupe LDLC SA
PA:ALLDL
|
0.127x |
|
GDB Holdings Bhd
KLSE:0198
|
0.267x |
|
Warehouse Group Ltd
PINK:WHGPF
|
-0.168x |
|
Best SA
WAR:BST
|
0.088x |
|
Atari SA
PINK:PONGF
|
-0.413x |
|
JNK Heaters Co. Ltd
KQ:126880
|
-0.035x |
|
Super Energy Corporation Public Company Limited
BK:SUPER
|
0.039x |
Annual Cash Flow Conversion Efficiency for Allied Biotech Corporation (2020–2024)
The table below shows the annual cash flow conversion efficiency of Allied Biotech Corporation from 2020 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | NT$1.20 Billion | NT$223.79 Million | 0.187x | +58.98% |
| 2023-12-31 | NT$1.17 Billion | NT$137.62 Million | 0.118x | -15.16% |
| 2022-12-31 | NT$1.18 Billion | NT$164.27 Million | 0.139x | +107.24% |
| 2021-12-31 | NT$1.08 Billion | NT$72.43 Million | 0.067x | +28.95% |
| 2020-12-31 | NT$1.15 Billion | NT$59.48 Million | 0.052x | -- |